A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

NCT03457792 ·Status: COMPLETED

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

NCT01357668 ·Status: ACTIVE_NOT_RECRUITING

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

TNFalfa Blocking Treatment of Spondylarthropathies

NCT00133315 ·Status: COMPLETED ·Phase: PHASE4

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan

NCT02335606 ·Status: COMPLETED

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Etanercept (Enbrel) in Undifferentiated Spondyloarthritis

NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2

Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis

NCT00938015 ·Status: COMPLETED

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 ·Status: TERMINATED

Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

NCT00794118 ·Status: COMPLETED

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Long-term Experience With Abatacept SC in Routine Clinical Practice

NCT02090556 ·Status: COMPLETED

Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs

NCT04139954 ·Status: UNKNOWN

Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

NCT00524381 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

NCT00195377 ·Status: COMPLETED

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139 ·Status: COMPLETED ·Phase: PHASE3

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

NCT01328522 ·Status: COMPLETED ·Phase: PHASE1

Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs

NCT03496831 ·Status: COMPLETED

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

NCT00195403 ·Status: COMPLETED

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis

NCT01299961 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

NCT02632890 ·Status: COMPLETED

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

NCT00195364 ·Status: COMPLETED

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

NCT00503139 ·Status: COMPLETED